NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
2.20
Dollar change
-0.07
Percentage change
-2.95
%
Index- P/E0.38 EPS (ttm)5.87 Insider Own2.25% Shs Outstand0.85M Perf Week-10.81%
Market Cap1.87M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.83M Perf Month-7.82%
Enterprise Value8.57M PEG- EPS next Q- Inst Own7.22% Short Float4.97% Perf Quarter-22.70%
Income4.38M P/S1.51 EPS this Y- Inst Trans72.72% Short Ratio0.11 Perf Half Y-34.51%
Sales1.24M P/B0.43 EPS next Y- ROA24.20% Short Interest0.04M Perf YTD-34.14%
Book/sh5.10 P/C1.84 EPS next 5Y- ROE138.38% 52W High8.92 -75.30% Perf Year-25.07%
Cash/sh1.20 P/FCF- EPS past 3/5Y- - ROIC37.60% 52W Low1.90 15.95% Perf 3Y-98.15%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin-180.01% Volatility13.98% 16.74% Perf 5Y-99.91%
Dividend TTM- EV/Sales6.91 EPS Y/Y TTM142.69% Oper. Margin-628.63% ATR (14)0.30 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.32 Sales Y/Y TTM- Profit Margin352.31% RSI (14)42.95 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.32 EPS Q/Q72.41% SMA20-7.89% Beta1.88 Target Price700.00
Payout0.00% Debt/Eq0.21 Sales Q/Q- SMA50-14.33% Rel Volume0.19 Prev Close2.27
Employees31 LT Debt/Eq0.17 Earnings- SMA200-29.91% Avg Volume379.98K Price2.20
IPOMay 12, 2015 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume73,299 Change-2.95%
Jun-26-25 07:37AM
Jun-12-25 08:00AM
Jun-05-25 09:00AM
May-30-25 07:00AM
May-07-25 04:01PM
07:00AM Loading…
May-01-25 07:00AM
Mar-27-25 09:25AM
Mar-17-25 07:00AM
Mar-05-25 07:30AM
Jan-06-25 07:31AM
Dec-16-24 09:25AM
Dec-05-24 08:25AM
Nov-27-24 08:00AM
08:00AM
Nov-22-24 07:15AM
06:59AM Loading…
Oct-31-24 06:59AM
Sep-16-24 07:00AM
Sep-09-24 11:12AM
Aug-29-24 06:31AM
Aug-21-24 08:45AM
Aug-20-24 09:30AM
Aug-15-24 07:00AM
Aug-13-24 07:00AM
Aug-05-24 06:30AM
Jul-23-24 07:00AM
Jul-15-24 12:41PM
12:22PM
12:04PM
07:00AM
Jul-08-24 08:14AM
09:32AM Loading…
Jul-03-24 09:32AM
Jul-02-24 01:52PM
08:12AM
Jun-21-24 07:52AM
Jun-17-24 07:56AM
07:40AM
Jun-13-24 07:00AM
Jun-07-24 07:00AM
Jun-03-24 10:52AM
May-24-24 04:01PM
May-15-24 04:01PM
May-06-24 09:21AM
Apr-10-24 07:00AM
Apr-08-24 07:00AM
Mar-12-24 08:00AM
Feb-29-24 08:45AM
Feb-13-24 07:00AM
Jan-25-24 10:26AM
Jan-04-24 04:01PM
06:15AM
Dec-29-23 09:21AM
Dec-27-23 07:15AM
Dec-20-23 08:05AM
Dec-12-23 07:26AM
Dec-11-23 08:11AM
Nov-29-23 09:25AM
Nov-20-23 07:30AM
Nov-06-23 07:30AM
Nov-03-23 04:30PM
Oct-31-23 09:00AM
08:23AM
Oct-30-23 07:00AM
Oct-04-23 07:30AM
Sep-19-23 04:05PM
Sep-15-23 09:01AM
Sep-13-23 04:13PM
Sep-11-23 07:30AM
Sep-06-23 06:00AM
Aug-11-23 09:00AM
Aug-01-23 04:01PM
Jul-11-23 08:17AM
Jun-05-23 07:00AM
May-30-23 06:00AM
May-15-23 04:45PM
Apr-17-23 04:25PM
Mar-16-23 01:10PM
Mar-06-23 01:31PM
Mar-03-23 02:07PM
Feb-02-23 02:15PM
Jan-23-23 11:50AM
06:25AM
Jan-06-23 07:15AM
Jan-05-23 07:00AM
Dec-30-22 07:30AM
Dec-21-22 11:00AM
Dec-20-22 12:42PM
Dec-16-22 08:48AM
Dec-12-22 07:06AM
Dec-08-22 11:05AM
Dec-06-22 08:30AM
07:30AM
Nov-30-22 09:15AM
Nov-29-22 07:00AM
Nov-21-22 06:00AM
Nov-15-22 08:33AM
Nov-10-22 04:00PM
Nov-03-22 11:30AM
Nov-02-22 04:30PM
Oct-18-22 07:55AM
Oct-11-22 02:00PM
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.